Cussenot O - Search Results

1

Genetic variability in 13q33 and 9q34 is linked to aggressiveness patterns and a higher risk of progression of non-muscle-invasive bladder cancer at the time of diagnosis.

Lenfant L, Cancel-Tassin G, Gazut S, Compérat E, Rouprêt M, Cussenot O. Lenfant L, et al. Among authors: cussenot o. BJU Int. 2021 Mar;127(3):375-383. doi: 10.1111/bju.15254. Epub 2020 Oct 15. BJU Int. 2021. PMID: 32975901

2

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.

Valeri A, Cormier L, Moineau MP, Cancel-Tassin G, Azzouzi R, Doucet L, Baschet F, Cussenot I, L'Her J, Berthon P, Mangin P, Cussenot O, Morin JF, Fournier G. Valeri A, et al. Among authors: cussenot o, cussenot i. J Urol. 2002 Aug;168(2):483-7. doi: 10.1016/s0022-5347(05)64663-0. J Urol. 2002. PMID: 12131293

3

Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.

Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, Berthon P, Cussenot O. Cancel-Tassin G, et al. Among authors: cussenot o. Eur Urol. 2003 Oct;44(4):487-90. doi: 10.1016/s0302-2838(03)00319-1. Eur Urol. 2003. PMID: 14499686

4

[Genetic susceptibility to prostate cancer].

Cussenot O, Cancel-Tassin G. Cussenot O, et al. Med Sci (Paris). 2004 May;20(5):562-8. doi: 10.1051/medsci/2004205562. Med Sci (Paris). 2004. PMID: 15190476 Free article. Review. French.

5

Expression in bladder transitional cell carcinoma by real-time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1-2: identification of 5 candidates tumor suppressor genes.

Amira N, Cancel-Tassin G, Bernardini S, Cochand-Priollet B, Bittard H, Mangin P, Fournier G, Latil A, Cussenot O. Amira N, et al. Among authors: cussenot o. Int J Cancer. 2004 Sep 10;111(4):539-42. doi: 10.1002/ijc.20283. Int J Cancer. 2004. PMID: 15239131

6

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

7

[Transitional cell carcinoma of the upper urinary tract new concepts in management].

Rouprêt M, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Presse Med. 2005 Apr 23;34(8):601-7. doi: 10.1016/s0755-4982(05)83989-2. Presse Med. 2005. PMID: 15962502 Review. French.

8

Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma.

Rouprêt M, Coulet F, Azzouzi AR, Fromont G, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. BJU Int. 2005 Jul;96(1):149-51. doi: 10.1111/j.1464-410X.2005.05585.x. BJU Int. 2005. PMID: 15963139

9

Microsatellite instability and transitional cell carcinoma of the upper urinary tract.

Rouprêt M, Azzouzi AR, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. BJU Int. 2005 Sep;96(4):489-92. doi: 10.1111/j.1464-410X.2005.05671.x. BJU Int. 2005. PMID: 16104897 Review. No abstract available.

10

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: cussenot o. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters